Nrf2 deficiency deteriorated CTX-induced myelosuppression in vitro/in vivo.
Nrf2 deficiency decreased antioxidant capacity of peripheral blood and bone marrow.
Nrf2 deficiency impaired hematopoietic proliferating and colony formation ability.
CDDO-Me Nrf2-dependently mitigated CTX-induced myelosuppression.